Cardiotoxicity of imatinib mesylate: an extremely rare phenomenon or a major side effect?

Ann Rheum Dis. 2007 Jun;66(6):836. doi: 10.1136/ard.2006.067710.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Benzamides
  • Heart Failure / chemically induced*
  • Humans
  • Imatinib Mesylate
  • Piperazines / adverse effects*
  • Protein Kinase Inhibitors / adverse effects*
  • Pyrimidines / adverse effects*

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate